Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health and changes regularly. See the Directory of published versions

: Regulated Authorization for Dovato 50 mg/300 mg film-coated tablets - JSON Representation

Raw json | Download


{
  "resourceType" : "RegulatedAuthorization",
  "id" : "authorization49178f16170ee8a6bc2a4361c1748d5f",
  "meta" : {
    "profile" : [
      🔗 "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: RegulatedAuthorization</b><a name=\"authorization49178f16170ee8a6bc2a4361c1748d5f\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource RegulatedAuthorization &quot;authorization49178f16170ee8a6bc2a4361c1748d5f&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-RegulatedAuthorization-uv-epi.html\">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: id:\u00a0EU/1/19/1370/001\u00a0(use:\u00a0OFFICIAL)</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-mp16598f252d07b4784b82ba43cf9e847e.html\">MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e</a></p><p><b>type</b>: Marketing Authorisation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (rmswi#100000072062)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2019-07-01 13:28:17+0000</p><p><b>holder</b>: <a href=\"Organization-mah-31ff1af739c7dcf77386a86f8dd83d29.html\">Organization/mah-31ff1af739c7dcf77386a86f8dd83d29</a> &quot;ViiV Healthcare BV&quot;</p><p><b>regulator</b>: <a href=\"Organization-mra-7c9b97127f73ff3605a10eb1c2cc24d1.html\">Organization/mra-7c9b97127f73ff3605a10eb1c2cc24d1</a> &quot;European Medicines Agency&quot;</p></div>"
  },
  "identifier" : [
    {
      "use" : "official",
      "system" : "https://spor.ema.europa.eu/pmswi",
      "value" : "EU/1/19/1370/001"
    }
  ],
  "subject" : [
    {
      🔗 "reference" : "MedicinalProductDefinition/mp16598f252d07b4784b82ba43cf9e847e"
    }
  ],
  "type" : {
    "coding" : [
      {
        "system" : "https://spor.ema.europa.eu/rmswi",
        "code" : "100000072062",
        "display" : "Marketing Authorisation"
      }
    ]
  },
  "status" : {
    "coding" : [
      {
        "system" : "http://hl7.org/fhir/publication-status",
        "code" : "active",
        "display" : "Active"
      }
    ]
  },
  "statusDate" : "2019-07-01T13:28:17Z",
  "holder" : {
    🔗 "reference" : "Organization/mah-31ff1af739c7dcf77386a86f8dd83d29"
  },
  "regulator" : {
    🔗 "reference" : "Organization/mra-7c9b97127f73ff3605a10eb1c2cc24d1"
  }
}